Dr. Satu Mustjoki, MD, PhD is a professor of Translational Hematology at the University of Helsinki, Finland and Head of the department at the Helsinki University Hospital Comprehensive Cancer Center. She is director of the Translational Immunology Research Program at the Faculty of Medicine, University of Helsinki, Finland (www.helsinki.fi/trimm) and scientific director of iCAN Digital Precision Cancer Medicine Flagship (www.ican.fi). Her own research group at the Hematology Research Unit Helsinki (www.helsinki.fi/hematology) consists of 25 members involving both basic and clinical scientists in hematology and immunology. Her group’s current research interests focus both on tumor immunology and on the molecular mechanisms of rare T-cell and NK cell malignancies and associated autoimmune disorders.